|
|
|
News For IPXL;MELI From The Last 14 Days Check below for free stories on IPXL;MELI the last two weeks. |
|
|
| May 22, 2013 | | 07:28 EDT |  | IPXL | UBS to host a conference
Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link | | | May 17, 2013 | | 08:41 EDT |  | IPXL | Impax commenced shipment of authorized generic Zomig
Impax (IPXL) announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig tablets, as part of an agreement with AstraZeneca (AZN). Zomig is indicated for the treatment of migraine headaches in adults. According to IMS Health data, U.S. sales of Zomig tablets and orally disintegrating tablets were approximately $196M in the 12 months ended April 2013. | | | May 15, 2013 | | 16:40 EDT | | MELI | MercadoLibre unit to pay $16.7M for parking spaces
 Subscribe for More Information | | | May 13, 2013 | | 07:49 EDT |  | IPXL | FDA decision on Opana a modest positive for Impax, says Leerink
Leerink views the FDA's denial of Endo's (ENDP) Citizen Petition as a modest positive for Impax (IPXL), which it notes is the sole holder of 180 day exclusivity on generic Opana. However, Leerink says upside for Impax will be limited as Actavis (ACT), Sandoz, and Teva (TEVA) have settlements to enter the market starting in June 2013 when Impax's 180-day generic exclusivity expires. | |
|
|
|
|
|
|
